These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19647612)

  • 21. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center.
    Wu HT; Peng KW; Ji ZH; Sun JH; Zhang Q; Yang XJ; Huang CQ; Li Y
    Eur J Surg Oncol; 2016 Jul; 42(7):1024-34. PubMed ID: 27179924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
    Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
    [No Abstract]   [Full Text] [Related]  

  • 23. Surgical treatment of patients with peritoneal surface malignancy: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Dunn D
    J Wound Ostomy Continence Nurs; 2010; 37(4):379-85. PubMed ID: 20644370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
    Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
    Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy.
    Kim KW; Chow O; Parikh K; Blank S; Jibara G; Kadri H; Labow DM; Hiotis SP
    Am J Surg; 2014 Jan; 207(1):78-83. PubMed ID: 24157224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
    Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
    Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An overview of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for the anesthesiologist.
    Webb CA; Weyker PD; Moitra VK; Raker RK
    Anesth Analg; 2013 Apr; 116(4):924-31. PubMed ID: 23460568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Postoperative Intraperitoneal Versus Hyperthermic Intraperitoneal Chemotherapy After Optimal Cytoreductive Surgery for Colorectal Cancer with Isolated Peritoneal Metastasis (ICARuS).
    Rossi AJ; Khan TM; Rehman SU; Nash GM; Hernandez JM
    Ann Surg Oncol; 2021 Aug; 28(8):4100-4101. PubMed ID: 34032959
    [No Abstract]   [Full Text] [Related]  

  • 29. Current status of cytoreductive surgery (CRS) and intraperitoneal hyperthermic chemotherapy (HIPEC) in the multimodal treatment of peritoneal surface malignancies.
    Klos D; Riško J; Stašek M; Loveček M; Hanuliak J; Skalický P; Lemstrová R; Mohelníková BD; Študentová H; Neoral Č; Melichar B
    Cas Lek Cesk; 2018 Dec; 157(8):419-428. PubMed ID: 30754979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal mesotheliomia [corrected].
    Sugarbaker PH
    Ann Surg Oncol; 2010 Jun; 17(6):1710-2; author reply 1713-4. PubMed ID: 20354799
    [No Abstract]   [Full Text] [Related]  

  • 31. Reply to "Peritoneal carcinomatosis in patients with gastric cancer and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy".
    Graziosi L; Marino E; Donini A
    Am J Surg; 2014 Jul; 208(1):158-9. PubMed ID: 24530090
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma.
    Tabrizian P; Franssen B; Jibara G; Sweeney R; Sarpel U; Schwartz M; Labow D
    J Surg Oncol; 2014 Dec; 110(7):786-90. PubMed ID: 25091997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indications and patient selection for cytoreductive surgery and perioperative intraperitoneal chemotherapy.
    González-Moreno S; Ortega-Pérez G; González-Bayón L
    J Surg Oncol; 2009 Sep; 100(4):287-92. PubMed ID: 19697424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life in patients with peritoneal surface malignancies after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Chia CS; Tan WJ; Wong JF; Tan GH; Lim C; Wang W; Sin EI; Tham CK; Soo KC; Teo MC
    Eur J Surg Oncol; 2014 Aug; 40(8):909-16. PubMed ID: 24768445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The current role of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of appendiceal tumors.
    Stewart JH; Levine EA; Shen P
    Curr Probl Cancer; 2009; 33(3):142-53. PubMed ID: 19647613
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cytoreductive surgery and HIPEC: a curative strategy for primary and secondary peritoneal tumors].
    Lehmann K; Gertsch P; Vonlanthen R
    Praxis (Bern 1994); 2013 Jul; 102(15):913-8. PubMed ID: 23876688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery for colorectal peritoneal carcinomatosis.
    Chua TC; Pelz JO; Morris DL
    Scand J Gastroenterol; 2012 Mar; 47(3):277-85. PubMed ID: 22263634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
    Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
    Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Peritoneal mesothelioma: treatment with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy].
    Passot G; Cotte E; Brigand C; Beaujard AC; Isaac S; Gilly FN; Glehen O
    J Chir (Paris); 2008; 145(5):447-53. PubMed ID: 19106865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritoneal surface malignancies and regional treatment: a review of the literature.
    Rubino MS; Abdel-Misih RZ; Bennett JJ; Petrelli NJ
    Surg Oncol; 2012 Jun; 21(2):87-94. PubMed ID: 21216590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.